Source: Regulatory Peptides. Unidade: FMRP
Subjects: ANOREXIA, PESOS E MEDIDAS CORPORAIS (EFEITOS DE DROGAS), HIPOTÁLAMO, NEUROPEPTÍDEOS, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RORATO, Rodrigo et al. Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus. Regulatory Peptides, v. 182, p. 12-18, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.regpep.2012.12.004. Acesso em: 09 nov. 2024.APA
Rorato, R., Miyahara, C., Antunes-Rodrigues, J., & Elias, L. L. K. (2013). Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus. Regulatory Peptides, 182, 12-18. doi:10.1016/j.regpep.2012.12.004NLM
Rorato R, Miyahara C, Antunes-Rodrigues J, Elias LLK. Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus [Internet]. Regulatory Peptides. 2013 ; 182 12-18.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.regpep.2012.12.004Vancouver
Rorato R, Miyahara C, Antunes-Rodrigues J, Elias LLK. Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus [Internet]. Regulatory Peptides. 2013 ; 182 12-18.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.regpep.2012.12.004
